iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer’s Disease 论文
2017Cell Reports引用 231顶会
Computational Drug Discovery MethodsAlzheimer's disease research and treatmentsCholinesterase and Neurodegenerative Diseases
iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer’s Disease · 相关事件
暂无数据